Pioglitazone

Product NDC
50090-6874
11-digit product format
500906874
Labeler code
50090
Product ID
50090-6874_3b1dc082-75a6-412f-8d58-e79677e4a9c2
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Pioglitazone
Dosage form
TABLET
Route
ORAL
Labeler
A-S Medication Solutions
Application
ANDA202467
Marketing category
ANDA
Marketing start
2022-08-18
Substance
PIOGLITAZONE HYDROCHLORIDE
Active strength
30 mg/1
Pharmacologic classes
Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor alpha Agonists [MoA], Peroxisome Proliferator-activated Receptor gamma Agonists [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Related Records

Related UNII Ingredients

UNIIPreferred termRegistry numberMatched term
JQT35NPK6CPIOGLITAZONE HYDROCHLORIDE112529-15-4PIOGLITAZONE HYDROCHLORIDE
X4OV71U42SPIOGLITAZONE111025-46-8Pioglitazone

Packages

Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
50090-6874-05009068740090 TABLET in 1 BOTTLE (50090-6874-0) 90 tablet2023-12-04NoNoHistorical

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
PioglitazoneA-S Medication Solutions2023-12-05Human Prescription Drug Label1